Not recruiting yet
Outside the Cage (OTC) Robotic Esophagectomy
NCT06735638 · Centre hospitalier de l'Université de Montréal (CHUM) · Updated 18 March 2026
- What is being tested
- OTC MIE Esophagectomy
- For
- Esophageal Cancer
- Kind of study
- Tests a treatment or device on volunteers. Phase 1.
- Who can join
- Ages 18 years and older. About 31 people. The full rules are on the registry page.
- Where
- Canada
- When
- Starts or started 1 Jan 2027, ends 1 Jan 2028. Registered 16 Dec 2024.
- Results
- None posted yet.
In the researchers' words
The goal of this clinical trial is to evaluate the feasibility and safety of a novel non-intercostal robotic approach for minimally invasive esophagectomy (OTC MIE) in the treatment of esophageal cancer. This study aims to determine whether OTC MIE reduces the risk of acute and chronic chest pain compared to traditional minimally invasive esophagectomy (MIE) and improves postoperative outcomes for patients. Participants will undergo either the OTC MIE procedure or a traditional MIE approach as part of their treatment for esophageal cancer. Postoperative outcomes, including chest pain and recovery metrics, will be closely monitored. Follow-up assessments will be conducted to evaluate the long-term safety and effectiveness of the novel approach. The investigators aim to recruit 31 patients.
Sites
- CHUMMontreal, Quebec, Canada